Drug pricing spotlight: Prenatal vitamins
How brand-name prenatal vitamins can cost 127x more
As new medications enter the market, we’ve observed a troubling new trend: An influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value.
Individually, the price exploitation of these drug categories may not be garnering national attention, but collectively, they drive higher spending for plan sponsors and greater affordability and access challenges for patients and clients.
This report shines a spotlight on the latest category: Prenatal vitamins.